News - Bayer, Germany

Filter

Current filters:

BayerGermany

Popular Filters

Malini Moorthy joins Bayer as head of litigation

Malini Moorthy joins Bayer as head of litigation

16-07-2014

Bayer Corporation, a US subsidiary of German drug major Bayer has hired Malini Moorthy as head of its…

BayerBayer CorporationBoardroomEconomy of GermanyGermanyHead of the litigation departmentIG FarbenMalini MoorthyPharmaceuticalUSA

Bayer explores Russian options in the context of Pharma 2020 strategy

Bayer explores Russian options in the context of Pharma 2020 strategy

28-05-2014

Bayer HealthCare, one of the business units of German drug major Bayer, is exploring all options for…

Abbott LaboratoriesBayerGermanyHealthcareManufacturing plantOzonPharmaceuticalPharmaceutical drugPharmacologyPoliticsRussia

Bayer to make clinical trial data more accessible to researchers

Bayer to make clinical trial data more accessible to researchers

14-05-2014

German drug major Bayer has joined a host of other pharma companies in announcing that it will start…

BayerBoehringer IngelheimGermanyHealth Medical PharmaPharmaceuticalPharmaceutical industryPharmaceutical sciencesResearchScience

Germany’s IQWiG views Xofigo, Kadcyla and Eviplera

03-04-2014

In an early benefit assessment under the Act on the Reform of the Market for Medicinal Products, the…

Anti-viralsBayerEvipleraGermanyGilead SciencesKadcylaNorthern EuropeOncologyPharmaceuticalPricingRegulationRocheXofigo

Bayer to invest 500 million-euro-plus in hemophilia products manufacturing in Germany

Bayer to invest 500 million-euro-plus in hemophilia products manufacturing in Germany

12-03-2014

German pharma major Bayer revealed yesterday that it plans an investment of more than 500 million euros…

BayerFinancialGermanyHematologyNorthern EuropePharmaceuticalProduction

Hint of minor added benefit for Bayer’s Stivarga seen by IQWiG

Hint of minor added benefit for Bayer’s Stivarga seen by IQWiG

13-01-2014

There was a hint of positive news for German drug major Bayer, when the German Institute for Quality…

BayerGermanyNorthern EuropeOncologyPharmaceuticalPricingRegulationStivarga

Added benefit of Bayer’s Eylea again not proven, says IQWiG

Added benefit of Bayer’s Eylea again not proven, says IQWiG

08-01-2014

For the third time in one year, the German Institute for Quality and Efficiency in Health Care (IQWiG)…

BayerEyleaGermanyNorthern EuropeOphthalmicsPharmaceuticalPricingRegulation

Kemal Malik appointed Bayer board member with responsibility for innovation

Kemal Malik appointed Bayer board member with responsibility for innovation

20-12-2013

The supervisory board of German drugs and chemicals major Bayer (BAYN: DE) has appointed Kemal Malik…

BayerBiotechnologyBoardroomGermanyPharmaceuticalUK

Bayer confirms plans to acquire Norway’s Algeta

Bayer confirms plans to acquire Norway’s Algeta

19-12-2013

German drugs and chemicals major Bayer has officially announced its intention to acquire Norwegian pharmaceutical…

AlgetaBayerGermanyMergers & AcquisitionsNorwayOncologyPharmaceuticalXofigo

Company Spotlight

Eleven Biotherapeutics

Eleven Biotherapeutics

Back to top